Episode 343: Journal Club including discussion of fibrates for DR, natural history of ERM, and more

Drs. Nicholas Farber, M. Ali Khan, and Safa Rahmani join for a journal club discussion of four recent publications in major ophthalmology journals:

1. Fibrates and Diabetic Retinopathy (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2790668)

2. Natural History of Epiretinal Membranes (https://www.ophthalmologyretina.org/article/S2468-6530(22)00087-2/fulltext#%20)

3. COVID-19 and Vascular Occlusions (https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2790988)

4. Google Searches for Thyroid Eye Disease and Teprotumumab (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2791596)

Relevant Financial Disclosures:
Dr. Sridhar is a consultant for Alcon, Allergan, Dorc, Genentech, and Regeneron. Dr. Khan, Dr. Farber, and Dr. Rahmani have no relevant disclosures.

CME Information

Release: May16, 2022; expires May 16, 2025

Reviewers: Xuejing Chen, MD, MS

Disclosures: The physician reviewers and Academy staff report no relevant financial disclosures.

Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of vitreoretinal disorders or the outcomes from recent research and how these impact patient care decisions.

Audience: This activity is intended for retina subspecialists and comprehensive ophthalmologists.

Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.